Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 1
1971 1
1986 1
1989 1
1996 2
1997 2
1999 2
2001 3
2002 1
2003 5
2004 1
2005 2
2006 1
2007 5
2008 3
2009 3
2010 3
2011 5
2012 6
2013 9
2014 5
2015 7
2016 7
2017 8
2018 13
2019 17
2020 13
2021 19
2022 24
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
Naimi A, Mohammed RN, Raji A, Chupradit S, Yumashev AV, Suksatan W, Shalaby MN, Thangavelu L, Kamrava S, Shomali N, Sohrabi AD, Adili A, Noroozi-Aghideh A, Razeghian E. Naimi A, et al. Cell Commun Signal. 2022 Apr 7;20(1):44. doi: 10.1186/s12964-022-00854-y. Cell Commun Signal. 2022. PMID: 35392976 Free PMC article. Review.
Given their suppressive effects on anti-tumor immunity, it has firmly been documented that ICIs based therapies can be practical and rational therapeutic approaches to treat cancer patients. Nonetheless, tumor inherent or acquired resistance to ICI and some treatment-relat …
Given their suppressive effects on anti-tumor immunity, it has firmly been documented that ICIs based therapies can be practical and rationa …
Preclinical Activity of SAR408701: A Novel Anti-CEACAM5-maytansinoid Antibody-drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors.
Decary S, Berne PF, Nicolazzi C, Lefebvre AM, Dabdoubi T, Cameron B, Rival P, Devaud C, Prades C, Bouchard H, Cassé A, Henry C, Amara C, Brillac C, Ferrari P, Maçon L, Lacoste E, Combeau C, Beys E, Naimi S, García-Echeverría C, Mayaux JF, Blanc V. Decary S, et al. Clin Cancer Res. 2020 Dec 15;26(24):6589-6599. doi: 10.1158/1078-0432.CCR-19-4051. Epub 2020 Oct 12. Clin Cancer Res. 2020. PMID: 33046521
Ectopic pregnancy: a single-center experience over ten years.
Al Naimi A, Moore P, Brüggmann D, Krysa L, Louwen F, Bahlmann F. Al Naimi A, et al. Reprod Biol Endocrinol. 2021 Jun 1;19(1):79. doi: 10.1186/s12958-021-00761-w. Reprod Biol Endocrinol. 2021. PMID: 34059064 Free PMC article.
Data on age, gravidity, parity, EP risk, amenorrhea duration, abdominal pain presence and location, beta-human chorionic gonadotropin (beta-HCG) level, ultrasound findings, therapeutic intervention, exact EP implantation site and length of hospital stay (LOS) were obtained …
Data on age, gravidity, parity, EP risk, amenorrhea duration, abdominal pain presence and location, beta-human chorionic gonadotropin (beta- …
Occupational Allergies to Cannabis.
Decuyper II, Green BJ, Sussman GL, Ebo DG, Silvers WS, Pacheco K, King BS, Cohn JR, Zeiger RS, Zeiger JS, Naimi DR, Beezhold DH, Nayak AP. Decuyper II, et al. J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3331-3338. doi: 10.1016/j.jaip.2020.09.003. J Allergy Clin Immunol Pract. 2020. PMID: 33161961 Free PMC article. Review.
Finally, we will discuss recent advances in the basic and translational scientific research that will aid the development of diagnostic tools and therapeutic standards to serve optimal management of cannabis allergies across the occupational spectrum....
Finally, we will discuss recent advances in the basic and translational scientific research that will aid the development of diagnostic tool …
Antimicrobial resistance.
Naimi T, Ringwald P, Besser R, Thompson S. Naimi T, et al. Emerg Infect Dis. 2001;7(3 Suppl):548. doi: 10.3201/eid0707.010727. Emerg Infect Dis. 2001. PMID: 11485665 Free PMC article. No abstract available.
Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
Bachert C, Laidlaw TM, Cho SH, Mullol J, Swanson BN, Naimi S, Classe M, Harel S, Jagerschmidt A, Laws E, Ruddy M, Praestgaard A, Amin N, Mannent LP. Bachert C, et al. Ann Otol Rhinol Laryngol. 2023 Dec;132(12):1649-1661. doi: 10.1177/00034894231176334. Epub 2023 Jun 15. Ann Otol Rhinol Laryngol. 2023. PMID: 37322842 Free PMC article.
These findings provide insight into the processes driving CRSwNP and the mechanisms of dupilumab's therapeutic effects. CLINICAL TRIAL REGISTRY NAME: SINUS-52 https://www.clinicaltrials.gov/ct2/show/NCT02898454. ...
These findings provide insight into the processes driving CRSwNP and the mechanisms of dupilumab's therapeutic effects. CLINICAL TRIA …
Sulfonylurea and neuroprotection: The bright side of the moon.
Hussien NR, Al-Naimi MS, Rasheed HA, Al-Kuraishy HM, Al-Gareeb AI. Hussien NR, et al. J Adv Pharm Technol Res. 2018 Oct-Dec;9(4):120-123. doi: 10.4103/japtr.JAPTR_317_18. J Adv Pharm Technol Res. 2018. PMID: 30637228 Free PMC article. Review.
167 results